{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,2]],"date-time":"2026-09-02T20:32:47Z","timestamp":1788381167489,"version":"build-2803163510"},"reference-count":32,"publisher":"Oxford University Press (OUP)","issue":"12","license":[{"start":{"date-parts":[[2020,11,20]],"date-time":"2020-11-20T00:00:00Z","timestamp":1605830400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/journals\/pages\/open_access\/funder_policies\/chorus\/standard_publication_model"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2021,6,15]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec><jats:title>Background<\/jats:title><jats:p>Coronavirus disease 2019 (COVID-19) has become a global pandemic. Clinical characteristics regarding secondary infections in patients with COVID-19 have been reported, but detailed microbiology, risk factors, and outcomes of secondary bloodstream infections (sBSIs) in patients with severe COVID-19 have not been well described.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>We performed a multicenter case-control study including all hospitalized patients diagnosed with severe COVID-19 and blood cultures drawn from 1 March 2020 to 7 May 2020 at 3 academic medical centers in New Jersey. Data collection included demographics, clinical and microbiologic variables, and patient outcomes. Risk factors and outcomes were compared between cases (sBSI) and controls (no sBSI).<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>A total of 375 hospitalized patients were included. There were 128 sBSIs during the hospitalization. For the first set of positive blood cultures, 117 (91.4%) were bacterial and 7 (5.5%) were fungal. Those with sBSI were more likely to have altered mental status, lower mean percentage oxygen saturation on room air, have septic shock, and be admitted to the intensive care unit compared with controls. In-hospital mortality was higher in those with an sBSI versus controls (53.1% vs 32.8%, P\u2005=\u2005.0001).<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusions<\/jats:title><jats:p>We observed that hospitalized adult patients with severe COVID-19 and sBSI had a more severe initial presentation, prolonged hospital course, and worse clinical outcomes. To maintain antimicrobial stewardship principles, further prospective studies are necessary to better characterize risk factors and prediction modeling to better understand when to suspect and empirically treat for sBSIs in severe COVID-19.<\/jats:p><\/jats:sec>","DOI":"10.1093\/cid\/ciaa1748","type":"journal-article","created":{"date-parts":[[2020,11,17]],"date-time":"2020-11-17T20:11:05Z","timestamp":1605643865000},"page":"e995-e1003","source":"Crossref","is-referenced-by-count":78,"title":["Risk Factors and Outcomes of Hospitalized Patients With Severe Coronavirus Disease 2019 (COVID-19) and Secondary Bloodstream Infections: A Multicenter Case-Control Study"],"prefix":"10.1093","volume":"72","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-8177-9903","authenticated-orcid":false,"given":"Pinki J","family":"Bhatt","sequence":"first","affiliation":[{"name":"Division of Allergy\/Immunology and Infectious Diseases, Department of Medicine, Rutgers Robert Wood Johnson Medical School, New Brunswick, New Jersey, USA"},{"name":"Department of Pharmacy Practice and Administration, Rutgers University Ernest Mario School of Pharmacy, Piscataway, New Jersey, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephanie","family":"Shiau","sequence":"additional","affiliation":[{"name":"Department of Biostatistics and Epidemiology, Rutgers School of Public Health, Piscataway, New Jersey, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luigi","family":"Brunetti","sequence":"additional","affiliation":[{"name":"Department of Pharmacy Practice and Administration, Rutgers University Ernest Mario School of Pharmacy, Piscataway, New Jersey, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yingda","family":"Xie","sequence":"additional","affiliation":[{"name":"Division of Infectious Diseases, Department of Medicine, Rutgers New Jersey Medical School, Newark, New Jersey, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kinjal","family":"Solanki","sequence":"additional","affiliation":[{"name":"Division of Allergy\/Immunology and Infectious Diseases, Department of Medicine, Rutgers Robert Wood Johnson Medical School, New Brunswick, New Jersey, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shaza","family":"Khalid","sequence":"additional","affiliation":[{"name":"Division of Infectious Diseases, Department of Medicine, Rutgers New Jersey Medical School, Newark, New Jersey, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sana","family":"Mohayya","sequence":"additional","affiliation":[{"name":"Department of Pharmacy, Robert Wood Johnson University Hospital, New Brunswick, New Jersey, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pak Ho","family":"Au","sequence":"additional","affiliation":[{"name":"Rutgers Robert Wood Johnson Medical School, New Brunswick, New Jersey, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christopher","family":"Pham","sequence":"additional","affiliation":[{"name":"Rutgers New Jersey Medical School, Newark, New Jersey, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Priyanka","family":"Uprety","sequence":"additional","affiliation":[{"name":"Department of Pathology and Laboratory Medicine, Rutgers Robert Wood Johnson Medical School, New Brunswick, New Jersey, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ronald","family":"Nahass","sequence":"additional","affiliation":[{"name":"ID Care, Hillsborough, New Jersey, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Navaneeth","family":"Narayanan","sequence":"additional","affiliation":[{"name":"Division of Allergy\/Immunology and Infectious Diseases, Department of Medicine, Rutgers Robert Wood Johnson Medical School, New Brunswick, New Jersey, USA"},{"name":"Department of Pharmacy Practice and Administration, Rutgers University Ernest Mario School of Pharmacy, Piscataway, New Jersey, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2020,11,20]]},"reference":[{"key":"2021061513451855500_CIT0001","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1056\/NEJMoa2001017","article-title":"A novel coronavirus from patients with pneumonia in China, 2019","volume":"382","author":"Zhu","year":"2020","journal-title":"N Engl J Med"},{"key":"2021061513451855500_CIT0002","author":"John Hopkins Coronavirus Resource Center"},{"key":"2021061513451855500_CIT0003","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1016\/S0140-6736(20)30183-5","article-title":"Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China","volume":"395","author":"Huang","year":"2020","journal-title":"Lancet"},{"key":"2021061513451855500_CIT0004","doi-asserted-by":"crossref","first-page":"1054","DOI":"10.1016\/S0140-6736(20)30566-3","article-title":"Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study","volume":"395","author":"Zhou","year":"2020","journal-title":"Lancet"},{"key":"2021061513451855500_CIT0005","doi-asserted-by":"crossref","first-page":"338","DOI":"10.3389\/fcimb.2017.00338","article-title":"Mechanisms of severe mortality-associated bacterial co-infections following influenza virus infection","volume":"7","author":"Jia","year":"2017","journal-title":"Front Cell Infect Microbiol"},{"key":"2021061513451855500_CIT0006","first-page":"327","article-title":"Secondary bacterial infections in influenza virus infection pathogenesis","volume":"385","author":"Smith","year":"2014","journal-title":"Curr Top Microbiol Immunol"},{"key":"2021061513451855500_CIT0007","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1186\/s12879-018-3548-0","article-title":"The role of pneumonia and secondary bacterial infection in fatal and serious outcomes of pandemic influenza a(H1N1)pdm09","volume":"18","author":"MacIntyre","year":"2018","journal-title":"BMC Infect Dis"},{"key":"2021061513451855500_CIT0008","first-page":"29","article-title":"Bacterial and fungal infections among patients with SARS-CoV-2 pneumonia","volume":"28","author":"Antinori","year":"2020","journal-title":"Infez Med"},{"key":"2021061513451855500_CIT0009","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1016\/S2213-2600(20)30079-5","article-title":"Clinical course and outcomes of critically ill patients with SARS-CoV-2 pneumonia in Wuhan, China: a single-centered, retrospective, observational study","volume":"8","author":"Yang","year":"2020","journal-title":"Lancet Respir Med"},{"key":"2021061513451855500_CIT0010","doi-asserted-by":"crossref","first-page":"104364","DOI":"10.1016\/j.jcv.2020.104364","article-title":"Clinical features and short-term outcomes of 221 patients with COVID-19 in Wuhan, China","volume":"127","author":"Zhang","year":"2020","journal-title":"J Clin Virol"},{"key":"2021061513451855500_CIT0011","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1016\/j.ajic.2008.03.002","article-title":"CDC\/NHSN surveillance definition of health care-associated infection and criteria for specific types of infections in the acute care setting","volume":"36","author":"Horan","year":"2008","journal-title":"Am J Infect Control"},{"key":"2021061513451855500_CIT0012","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1111\/j.1524-4733.2006.00130.x","article-title":"Too much ado about propensity score models? Comparing methods of propensity score matching","volume":"9","author":"Baser","year":"2006","journal-title":"Value Health"},{"key":"2021061513451855500_CIT0013","first-page":"1","article-title":"A general SAS macro to implement optimal N: 1 propensity score matching within a maximum radius","author":"Murphy","year":"2017"},{"key":"2021061513451855500_CIT0014","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1016\/j.jinf.2020.05.046","article-title":"Co-infections in people with COVID-19: a systematic review and meta-analysis","volume":"81","author":"Lansbury","year":"2020","journal-title":"J Infect"},{"key":"2021061513451855500_CIT0015","doi-asserted-by":"crossref","first-page":"e00875","DOI":"10.1128\/JCM.00875-20","article-title":"Bacteremia and blood culture utilization during COVID-19 surg","volume":"58","author":"Sepulveda","year":"2020","journal-title":"J Clin Microbiol"},{"key":"2021061513451855500_CIT0016","doi-asserted-by":"crossref","first-page":"1395","DOI":"10.1016\/j.cmi.2020.06.025","article-title":"Bacterial and fungal coinfection among hospitalized patients with COVID-19: a retrospective cohort study in a UK secondary-care setting","volume":"26","author":"Hughes","year":"2020","journal-title":"Clin Microbiol Infect"},{"key":"2021061513451855500_CIT0017","doi-asserted-by":"crossref","first-page":"e48","DOI":"10.1016\/S2213-2600(20)30237-X","article-title":"Prevalence of putative invasive pulmonary aspergillosis in critically ill patients with COVID-19","volume":"8","author":"Alanio","year":"2020","journal-title":"Lancet Respir Med"},{"key":"2021061513451855500_CIT0018","doi-asserted-by":"crossref","first-page":"1636","DOI":"10.3201\/eid2607.201603","article-title":"Fatal invasive aspergillosis and coronavirus disease in an immunocompetent patient","volume":"26","author":"Blaize","year":"2020","journal-title":"Emerg Infect Dis"},{"key":"2021061513451855500_CIT0019","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1111\/myc.13096","article-title":"COVID-19 associated pulmonary aspergillosis","volume":"63","author":"Koehler","year":"2020","journal-title":"Mycoses"},{"key":"2021061513451855500_CIT0020","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1164\/rccm.202004-1038LE","article-title":"COVID-19-associated pulmonary aspergillosis","volume":"202","author":"van Arkel","year":"2020","journal-title":"Am J Respir Crit Care Med"},{"key":"2021061513451855500_CIT0021","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1515\/dx-2020-0046","article-title":"Clinical features, laboratory characteristics, and outcomes of patients hospitalized with coronavirus disease 2019 (COVID-19): early report from the United States","volume":"7","author":"Aggarwal","year":"2020","journal-title":"Diagnosis (Berl)"},{"key":"2021061513451855500_CIT0022","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1016\/j.jmii.2013.06.002","article-title":"Clinical characteristics of children and adults hospitalized for influenza virus infection","volume":"47","author":"Leung","year":"2014","journal-title":"J Microbiol Immunol Infect"},{"key":"2021061513451855500_CIT0023","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1097\/MCC.0000000000000638","article-title":"Severe influenza: overview in critically ill patients","volume":"25","author":"Sarda","year":"2019","journal-title":"Curr Opin Crit Care"},{"key":"2021061513451855500_CIT0024","doi-asserted-by":"crossref","first-page":"101044","DOI":"10.1016\/j.molmet.2020.101044","article-title":"Diabetes, infection risk and COVID-19","volume":"39","author":"Erener","year":"2020","journal-title":"Mol Metab"},{"key":"2021061513451855500_CIT0025","doi-asserted-by":"crossref","first-page":"e3319","DOI":"10.1002\/dmrr.3319","article-title":"Diabetes is a risk factor for the progression and prognosis of COVID-19","author":"Guo","year":"2020","journal-title":"Diabetes Metab Res Rev"},{"key":"2021061513451855500_CIT0026","doi-asserted-by":"crossref","first-page":"104354","DOI":"10.1016\/j.jcv.2020.104354","article-title":"Diabetic patients with COVID-19 infection are at higher risk of ICU admission and poor short-term outcome","volume":"127","author":"Roncon","year":"2020","journal-title":"J Clin Virol"},{"key":"2021061513451855500_CIT0027","doi-asserted-by":"crossref","first-page":"923","DOI":"10.15585\/mmwr.mm6928e1","article-title":"Characteristics of persons who died with COVID-19\u2014United States, February 12\u2013May 18, 2020","volume":"69","author":"Wortham","year":"2020","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"2021061513451855500_CIT0028","doi-asserted-by":"crossref","first-page":"ciaa530","DOI":"10.1093\/cid\/ciaa530","article-title":"Bacterial and fungal co-infection in individuals with coronavirus: a rapid review to support COVID-19 antimicrobial prescribing","author":"Rawson","year":"2020","journal-title":"Clin Infect Dis"},{"key":"2021061513451855500_CIT0029","doi-asserted-by":"crossref","first-page":"1041","DOI":"10.3389\/fmicb.2017.01041","article-title":"Secondary bacterial infections associated with influenza pandemics","volume":"8","author":"Morris","year":"2017","journal-title":"Front Microbiol"},{"key":"2021061513451855500_CIT0030","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1016\/j.jmii.2020.05.013","article-title":"Co-infections among patients with COVID-19: the need for combination therapy with non-anti-SARS-CoV-2 agents?","volume":"53","author":"Lai","year":"2020","journal-title":"J Microbiol Immunol Infect"},{"key":"2021061513451855500_CIT0031","doi-asserted-by":"crossref","first-page":"659","DOI":"10.3949\/ccjm.87a.ccc015","article-title":"Recognition and management of respiratory coinfection and secondary bacterial pneumonia in patients with COVID-19","volume":"87","author":"Wu","year":"2020","journal-title":"Cleve Clin J Med"},{"key":"2021061513451855500_CIT0032","doi-asserted-by":"crossref","first-page":"e55","DOI":"10.1016\/j.jinf.2020.06.056","article-title":"Improving antibiotic stewardship in COVID-19: bacterial co-infection is less common than with influenza","volume":"81","author":"Youngs","year":"2020","journal-title":"J Infect"}],"container-title":["Clinical Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/cid\/advance-article-pdf\/doi\/10.1093\/cid\/ciaa1748\/34900049\/ciaa1748.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"http:\/\/academic.oup.com\/cid\/article-pdf\/72\/12\/e995\/38648014\/ciaa1748.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"http:\/\/academic.oup.com\/cid\/article-pdf\/72\/12\/e995\/38648014\/ciaa1748.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,12]],"date-time":"2023-10-12T14:54:27Z","timestamp":1697122467000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/cid\/article\/72\/12\/e995\/5995838"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,11,20]]},"references-count":32,"journal-issue":{"issue":"12","published-online":{"date-parts":[[2020,11,20]]},"published-print":{"date-parts":[[2021,6,15]]}},"URL":"https:\/\/doi.org\/10.1093\/cid\/ciaa1748","relation":{},"ISSN":["1058-4838","1537-6591"],"issn-type":[{"value":"1058-4838","type":"print"},{"value":"1537-6591","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2021,6,15]]},"published":{"date-parts":[[2020,11,20]]}}}